Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS

Journal of Immunological Methods

Volumn 242, Issue 1-2, 2000, Pages 79-89

  De Haas, Carla J C ^a   Van Leeuwen, Henk J ^a   Verhoef, Jan ^a   Van Kessel, Kok P M ^a   Van Strijp, Jos A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

A myloid P; FITC labeled; Gel filtration; Lipopolysaccharide binding; Lipoproteins

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; CD14 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; HIGH DENSITY LIPOPROTEIN; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; SERUM ALBUMIN; SERUM AMYLOID P;

ANALYTIC METHOD; ARTICLE; BINDING KINETICS; BIOSENSOR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; GEL FILTRATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION;

AMYLOID P COMPONENT; ANTIGENS, CD14; BLOOD PROTEINS; CARRIER PROTEINS; CHROMATOGRAPHY, GEL; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENCE; FLUORESCENT DYES; HUMAN; LIPOPOLYSACCHARIDES; LIPOPROTEINS, HDL; SERUM ALBUMIN;

EID: 0034726410     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(00)00207-6     Document Type: Article

References (33)

1. Bone R.C. The pathogenesis of sepsis. Ann. Intern. Med. 115:1991;457.
2. Brandenburg K., Mayer H., Koch M.H.J., Weckesser J., Rietschel E.T., Seydel U. Influence of the supramolecular structure of free lipid A on its biological activity. Eur. J. Biochem. 218:1993;555.
3. Brandenburg K., Seydel U., Schromm A.B., Loppnow H., Koch M.H.J., Rietschel E.T. Conformation of lipid A, the endotoxic center of bacterial lipopolysaccharide. J. Endotoxin Res. 3:1996;173.
4. Cavaillon J.M., Fitting C., Haeffner-Cavaillon N., Kirsch S.J., Warren H.S. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect. Immun. 58:1990;2375.
5. de Haas C.J.C., Haas P.-J., Van Kessel K.P.M., Van Strijp J.A.G. Affinities of different proteins and peptides for lipopolysaccharide (LPS) as determined by biosensor technology. Biochem. Biophys. Res. Commun. 252:1998;492.
6. de Haas C.J.C., Van der Tol M.E., Van Kessel K.P.M., Verhoef J., Van Strijp J.A.G. A synthetic lipopolysaccharide(LPS)-binding peptide based on amino acids 27-39 of Serum Amyloid P component inhibits LPS-induced responses in human blood. J. Immunol. 161:1998;3607.
7. Dziarski R. Cell-bound albumin is the 70-kDa peptidoglycan-, lipopolysaccharide-, and lipoteichoic acid-binding protein on lymphocytes and macrophages. J. Biol. Chem. 269:1994;20431.
8. Emsley J., White H.E., O'Hara B.P., Oliva G., Srinivasan N., Tickle I.J., Blundell T.L., Pepys M.B., Wood S.P. Structure of pentameric human serum amyloid P component. Nature. 367:1994;338.
9. Feingold K.R., Funk J.L., Moser A.H., Shigenaga J.K., Rapp J.H., Griinfeld C. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect. Immun. 63:1995;2041.
10. Galanos C., Rietschel E.T., Lüideritz O., Westphal O. Interaction of lipopolysaccharides and lipid A with complement. Eur. J. Biochem. 19:1971;143.
11. Hailman E., Lichenstein H.S., Wurfel M.M., Miller D.S., Johnson D.A., Kelley M., Busse L.A., Zukowski M.M., Wright S.D. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:1994;269.
12. Hailman E., Vasselon T., Kelley M., Busse L.A., Hu M.C.T., Lichenstein H.S., Detmers P.A., Wright S.D. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J. Immunol. 156:1996;4384.
13. Harris H.W., Grtinfeld C., Feingold K.R., Rapp J.H. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest. 86:1990;696.
14. Harris H.W., Griinfeld C., Feingold K.R., Read T.E., Kane J.P., Jones A.L., Eichbaum E.B., Bland G.F., Rapp J.H. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J. Clin. Invest. 91:1993;1028.
15. Haziot A., Chen S., Ferrero E., Low M.G., Silber R., Goyert S.M. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141:1988;547.
16. Jarvis B.W., Lichenstein H., Qureshi N. Diphosphoryl lipid A from Rhodobacter sphaeroides inhibits complexes that form in vitro between lipopolysaccharide (LPS)-binding protein, soluble CD14, and spectrally pure LPS. Infect. Immun. 65:1997;3011.
17. Juan T.S., Hailman E., Kelley M.J., Busse L.A., Davy E., Empig C.J., Narhi L.O., Wright S.D., Lichenstein H.S. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J. Biol. Chem. 270:1995;5219.
18. Pajkrt D., Doran J.E., Koster F., Lerch P.G., Arnet B., Van der Poll T., ten Cate J.W., Van Deventer S.J.H. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J. Exp. Med. 184:1996;1601.
19. Parker T.S., Levine D.M., Chang J.C., Laxer J., Coffin C.C., Rubin A.L. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect. Immun. 63:1995;253.
20. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos F., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and CS7BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085.
21. Pugin J., Schurer Maly C.C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA. 90:1993;2744.
22. Redgrave T.G., Roberts D.C.K., West C.E. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65:1975;42.
23. Roth R.I., Levin F.C., Levin J. Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin. Infect. Immun. 61:1993;3209.
24. Tall A.R., Small D.M. Plasma high-density lipoproteins. N. Engl. J. Med. 299:2000;1232.
25. Tobias P.S., Soldau K., Gegner J.A., Mintz D., Ulevitch R.J. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:1995;10482.
26. Troelstra A., Antal-Szalmas P., de Graaf-Miltenburg L.A.M., Weersink A.J.L., Verhoef J., Van Kessel K.P.M., Van Strijp J.A.G. Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes. Infect. Immun. 65:1997;2272.
27. Ulevitch R.J., Johnston A.R., Weinstein D.B. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J. Clin. Invest. 64:1979;1516.
28. Van Lenten B.J., Fogelman A.M., Haberland M.E., Edwards P.A. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 83:1986;2704.
29. Vosbeck K., Tobias P., Mueller H., Allen R.A., Arfors K.-E., Ulevitch R.J., Skilar L.A. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J. Leukoc. Biol. 47:1990;97.
30. Wright S.D., Ramos R.A., Hermanowski Vosatka A., Rockwell P., Detmers P.A. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173:1991;1281.
31. Wurfel M.M., Kunitake S.T., Lichenstein H., Kane J.P., Wright S.D. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180:1994;1025.
32. Wurfel M.M., Hailman E., Wright S.D. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181:1995;1743.
33. Yu B., Wright S.D. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J. Biol. Chem. 271:1996;4100.